Anti-Diabetic Activity of 2,3,6-Tribromo-4,5-Dihydroxybenzyl Derivatives from Symphyocladia latiuscula through PTP1B Downregulation and α-Glucosidase Inhibition
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-Diabetic Activity of 2,3,6-Tribromo-4,5-Dihydroxybenzyl Derivatives from Symphyocladia latiuscula through PTP1B Downregulation and α-Glucosidase Inhibition
Authors
Keywords
-
Journal
Marine Drugs
Volume 17, Issue 3, Pages 166
Publisher
MDPI AG
Online
2019-03-15
DOI
10.3390/md17030166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis, α- glucosidase inhibition and molecular docking study of coumarin based derivatives
- (2018) Muhammad Taha et al. BIOORGANIC CHEMISTRY
- Inhibitory mechanism of two allosteric inhibitors, oleanolic acid and ursolic acid on α-glucosidase
- (2018) Huafang Ding et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Protein Tyrosine Phosphatase 1B Inhibition and Glucose Uptake Potentials of Mulberrofuran G, Albanol B, and Kuwanon G from Root Bark of Morus alba L. in Insulin-Resistant HepG2 Cells: An In Vitro and In Silico Study
- (2018) Pradeep Paudel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors
- (2018) Shahira Ezzat et al. MOLECULES
- Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors
- (2017) Renshuai Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- α-Glucosidase inhibitory effect of Potentilla astracanica and some isoflavones: Inhibition kinetics and mechanistic insights through in vitro and in silico studies
- (2017) Didem Şöhretoğlu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Chemical Diversity from a Chinese Marine Red Alga, Symphyocladia latiuscula
- (2017) Xiuli Xu et al. Marine Drugs
- Looking Back, Looking Forward at Halogen Bonding in Drug Discovery
- (2017) Lois Mendez et al. MOLECULES
- Retrospective analysis of natural products provides insights for future discovery trends
- (2017) Cameron R. Pye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Marinocyanins, cytotoxic bromo-phenazinone meroterpenoids from a marine bacterium from the streptomycete clade MAR4
- (2017) Ratnakar N. Asolkar et al. TETRAHEDRON
- Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents
- (2016) Su Hui Seong et al. JOURNAL OF ETHNOPHARMACOLOGY
- MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels
- (2016) Arvindhan Nagarajan et al. Nature Communications
- Bastadins, brominated-tyrosine derivatives, suppress accumulation of cholesterol ester in macrophages
- (2015) Keisuke Eguchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies
- (2015) Muhammad Taha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Statistical Research on the Bioactivity of New Marine Natural Products Discovered during the 28 Years from 1985 to 2012
- (2015) Yiwen Hu et al. Marine Drugs
- Biological Activity of Recently Discovered Halogenated Marine Natural Products
- (2015) Gordon Gribble Marine Drugs
- Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice
- (2015) Zhi-Qin Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bis(2,3-dibromo-4,5-dihydroxybenzyl) Ether, a Marine Algae Derived Bromophenol, Inhibits the Growth of Botrytis cinerea and Interacts with DNA Molecules
- (2014) Ming Liu et al. Marine Drugs
- Pharmacological Inhibition of Protein Tyrosine Phosphatase 1B: A Promising Strategy for the Treatment of Obesity and Type 2 Diabetes Mellitus
- (2013) E. Panzhinskiy et al. CURRENT MEDICINAL CHEMISTRY
- The Power of Enzyme Kinetics in the Drug Development Process
- (2013) Alberta Samuele et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- α-Glucosidase inhibition by luteolin: Kinetics, interaction and molecular docking
- (2013) Jiakai Yan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Halogen Bond: Its Role beyond Drug–Target Binding Affinity for Drug Discovery and Development
- (2013) Zhijian Xu et al. Journal of Chemical Information and Modeling
- Marine Pharmacology in 2009–2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of Action
- (2013) Alejandro Mayer et al. Marine Drugs
- Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis
- (2013) Evgeniy Panzhinskiy et al. PLoS One
- Application of marine biomaterials for nutraceuticals and functional foods
- (2012) Chen Zhang et al. FOOD SCIENCE AND BIOTECHNOLOGY
- Bromophenols from marine algae with potential anti-diabetic activities
- (2012) Xiukun Lin et al. Journal of Ocean University of China
- Extraction and PTP1B inhibitory activity of bromophenols from the marine red alga Symphyocladia latiuscula
- (2011) Xu Liu et al. CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY
- Marine natural products: a new wave of drugs?
- (2011) Rana Montaser et al. Future Medicinal Chemistry
- Halogenated Compounds from Marine Algae
- (2010) Maria Teresa Cabrita et al. Marine Drugs
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started